Your investments deserve an analyst, not a dashboard.

Quarterly results

standalone · as filed with NSE · Q1 FY27 back to Q1 FY19

₹ crore	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19
Revenue from operations	155	120	93.5	84.4	59.8	56.5	46.4	41.6	39.1	62.9	40.1	34.5	33.7	41.5	41.8	45.2	30.8	31.4	39.6	46.7	29.5	27.9	41.3	43	42.1	34.1	36.9	10.1	20.3	17.3
Other income	2.3	12.1	10.9	5.8	4.9	4.6	4.4	5.7	4.9	3	0.7	2	1.5	2	1.2	1	0.7	1.1	2.1	1.1	1.4	0.5	1.4	0.6	0.8	1.3	0.5	1.1	1	0.8
Total expenses	97	84.6	61.1	58	45.2	45.1	36.7	33.1	33.5	33.7	29	30	33	32.3	29.7	34	25.8	25.7	33.3	35.3	21.5	20.6	28.8	30.5	28.8	24	31.1	8.5	15.2	12.2
EBITDA	60.1	37.5	34.3	28.4	16.5	13.4	11.4	10.3	6.7	30.9	12.1	5.2	1.8	10.6	12.9	12	5.8	6.5	6.9	12.2	8.7	8.1	13.4	13.3	14.2	10.7	6.4	2.1	5.6	5.6
EBITDA margin	38.8%	31.3%	36.7%	33.6%	27.6%	23.8%	24.6%	24.7%	17.0%	49.1%	30.3%	15.2%	5.4%	25.5%	30.9%	26.5%	18.8%	20.9%	17.5%	26.1%	29.7%	29.2%	32.4%	31.0%	33.6%	31.4%	17.4%	20.5%	27.7%	32.1%
Finance costs	1.1	0.9	0.6	0.7	0.6	0.8	0.4	0.6	0.2	0.9	0.4	0.1	0.4	0.6	0.1	0.1	0.1	0	0	0	0.1	0.2	0.2	0.2	0.1	0	0	0	0	0
Depreciation	1.3	1.3	1.3	1.3	1.2	1.3	1.3	1.2	0.8	0.7	0.8	0.7	0.7	0.8	0.8	0.7	0.7	0.8	0.6	0.7	0.7	0.6	0.6	0.6	0.7	0.5	0.5	0.5	0.5	0.5
Profit before tax	59.9	47.5	43.3	32.2	19.6	16	14.1	14.2	10.6	32.2	11.7	6.4	2.2	11.2	13.2	12.2	5.7	6.8	8.4	12.6	9.4	7.8	13.9	13.1	14.2	11.5	6.3	2.6	6.2	5.8
Tax	15.8	11.2	10.4	8.1	4.5	4.5	3	4.2	2.3	8.5	2.9	1.3	0.1	2.9	3.2	3.6	1.1	2.6	1.9	3.1	2.3	1.9	3.5	2.9	3.2	3.3	1.9	0.6	1.8	1.3
Net profit	44.2	36.3	32.9	24.1	15	11.6	11.1	10	8.3	23.7	8.9	5.1	2.2	8.3	10	8.6	4.6	4.2	6.5	9.5	7.1	5.9	10.4	10.2	11	8.2	4.4	2	4.3	4.5
Net margin	28.5%	30.2%	35.1%	28.6%	25.1%	20.5%	23.9%	24.2%	21.1%	37.7%	22.1%	14.8%	6.4%	20.1%	24.0%	19.0%	15.0%	13.4%	16.4%	20.3%	24.0%	21.2%	25.3%	23.8%	26.2%	23.9%	11.8%	20.2%	21.3%	25.9%
EPS (₹)	0.33	0.27	1.22	0.90	0.56	0.43	0.41	0.37	0.31	1.78	6.65	3.84	1.62	6.25	7.52	6.43	3.47	3.14	4.85	7.13	5.31	4.44	7.82	7.66	8.27	6.12	3.27	1.53	3.90	4.03
Net profit YoY	+194.1%	+213.9%	+196.6%	+140.2%	+81.9%	−51.3%	+25.0%	+96.2%	+282.6%	+184.5%	−11.7%	−40.4%	−53.4%	+99.0%	–	–	–	−35.3%	−37.9%	−6.9%	−35.8%	−27.4%	+139.5%	+401.7%	+154.4%	+82.1%	–	–	–	–

Annual results

financial years ending March · from the fourth-quarter filings

₹ crore	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19
Revenue from operations	358	184	171	159	133	144	161	85.5
Other income	33.7	19.7	7.2	4.8	4.3	5.2	3.4	2.5
Total expenses	249	148	126	122	113	111	112	67
EBITDA	117	41.8	50.1	41.3	23	36	52.3	20.6
EBITDA margin	32.6%	22.8%	29.3%	25.9%	17.3%	25.1%	32.5%	24.1%
Finance costs	2.8	2.1	1.8	0.8	0.1	0.4	0.5	0.1
Depreciation	5.1	4.5	2.9	3	2.6	2.6	2.5	2
Profit before tax	142	54.9	52.6	42.3	24.5	38.2	52.7	20.9
Tax	34.2	14	12.7	10.7	7.2	9.2	12.9	5.7
Net profit	108	40.9	39.9	31.6	17.3	29	39.8	15.2
Net margin	30.3%	22.3%	23.3%	19.8%	13.0%	20.2%	24.7%	17.8%
EPS (₹)	0.81	1.52	2.98	23.68	12.95	21.73	29.87	11.40
Net profit YoY	+164.5%	+2.7%	+26.2%	+82.8%	−40.4%	−27.3%	+162.0%	–

EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore

₹ crore	FY26	FY25	FY24	FY23	FY22
Operating cash flow	46.1	−11.1	7.8	32.7	10.2
Investing cash flow	28.1	44.7	−79.8	−21.9	−13.5
Financing cash flow	35.3	−1.5	98.8	−10.9	2.7
Capital expenditure	24.7	19.5	89.4	2.5	8.6
Free cash flow (CFO − capex)	21.4	−30.6	−81.6	30.2	1.6

Net profit trend

annual, ₹ crore

FY21

₹29

FY22

₹17.3−40%

FY23

₹31.6+83%

FY24

₹39.9+26%

FY25

₹40.9+3%

FY26

₹108+165%

Result filings

as filed with NSE · PDF and XBRL

Period	Basis	Filed	Documents
Q1 FY27	Consolidated	7 Aug 2026	PDF on NSE XBRL
Q1 FY27	Standalone	7 Aug 2026	PDF on NSE XBRL
Q4 FY26	Consolidated · audited	15 May 2026	PDF on NSE XBRL
Q4 FY26	Standalone · audited	15 May 2026	PDF on NSE XBRL
Q3 FY26	Consolidated	29 Jan 2026	PDF on NSE XBRL
Q3 FY26	Standalone	29 Jan 2026	PDF on NSE XBRL
Q2 FY26	Consolidated	12 Nov 2025	PDF XBRL
Q2 FY26	Standalone	12 Nov 2025	PDF XBRL
Q1 FY26	Consolidated	8 Aug 2025	PDF XBRL
Q1 FY26	Standalone	8 Aug 2025	PDF XBRL

Annual reports

NSE archive

FY254.54 MB FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16

Key ratios

P/E (TTM)5Y avg 59.2×264.2×

P/B5Y avg 8.74×80.53×

ROEFY26, on average equity27.3%

Net margin30.3%

Debt / equity0.11×

Revenue CAGR (3Y)30.9%

Profit CAGR (3Y)50.8%

EPS (TTM)₹1.02

Market cap₹36,306 Cr

Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.

P/B vs history

80.53×

vs 8-point avg 8.74× (+822%)

2.03× low8.74× avg80.53× high

History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.

Balance sheet 31 Mar 2026

Total assets₹553 Cr+49%

Net worth₹451 Cr+32%

Total borrowings₹51 Cr+303%

Cash & bank balances₹169 Cr+185%

Investments₹75 Cr−27%

Inventories₹70 Cr+68%

Trade receivables₹101 Cr+50%

Trade payables₹30 Cr+2337%

Change vs the same date a year earlier.

Revenue mix FY24

a) Male and Female Contraceptives & Jelly98.0%result ₹46.2 Cr

b) In Vitro Devices (IVD)2.0%result ₹−0.9 Cr

Segment revenue as reported, before inter-segment eliminations.

Shareholding 30 Jun 2026

%	Jun 26	Mar 26	Mar 26	Dec 25	Sept 25	Jun 25	Mar 25	Dec 24	Sept 24	Jun 24	Apr 24	Mar 24
Promoter	46.24	46.03	45.95	45.55	45.55	42.52	42.52	42.52	45.61	44.80	44.80	44.80
FII	4.17	1.01	0.91	1.48	2.58	0.95	1.63	3.14	3.33	5.97	5.39	5.20
DII	0.34	0.17	0.08	0.30	0.34	0.11	0.11	0.00	0.00	0.34	1.04	1.08
of which MF	0.33	0.15	0.00	0.10	0.16	–	–	–	–	–	–	–
Retail	24.64	25.36	24.74	25.35	24.04	23.35	27.74	27.74	25.25	25.31	25.43	25.82
Other public	24.61	27.43	28.32	27.32	27.49	33.07	28.00	26.60	25.81	23.58	23.34	23.10

2,95,432 shareholders · NSE shareholding pattern filings.